Yingli He

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Hepatitis B Virus

Dna Methylation

Top Venues

Journal of virology

Current drug targets

This page only lists publications with an associated author ORCID identifier.

Publications

Qijuan Zang, Yalin Ju, Siyi Liu, Shaobo Wu, Chengbin Zhu, Liangru Liu, Weicheng Xu, Yingli He
The significance of m6A RNA methylation regulators in diagnosis and subtype classification of HBV-related hepatocellular carcinoma. Human cell 37 (3) (2024)
Qijuan Zang, Yalin Ju, Siyi Liu, Shaobo Wu, Chengbin Zhu, Liangru Liu, Weicheng Xu, Yingli He
The significance of m6A RNA methylation regulators in diagnosis and subtype classification of HBV-related hepatocellular carcinoma. Human cell (2024)
Qijuan Zang, Yalin Ju, Siyi Liu, Shaobo Wu, Chengbin Zhu, Liangru Liu, Weicheng Xu, Yingli He
The significance of m6A RNA methylation regulators in diagnosis and subtype classification of HBV-related hepatocellular carcinoma. Human cell 37 (3) (2024)
Qijuan Zang, Yalin Ju, Siyi Liu, Shaobo Wu, Chengbin Zhu, Liangru Liu, Weicheng Xu, Yingli He
The significance of m6A RNA methylation regulators in diagnosis and subtype classification of HBV-related hepatocellular carcinoma. Human cell 37 (3) (2024)
Bo Wu, Tingting Fan, Xinrui Chen, Yingli He, Hongliang Wang
The class III phosphatidylinositol 3-kinase VPS34 supports EV71 replication by promoting viral replication organelle formation. Journal of virology (2024)
Yingli He, Xiaoli Zhang, Yalei Zhao, Liangru Liu
Syndecan-1: A Novel Diagnostic and Therapeutic Target in Liver Diseases. Current drug targets (2023)